Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRESPA golimumab induction study in early peripheral spondyloarthritis
2011-003678-97Phase 3Completed
- Sponsor
- Ghent University Hospital
- Start
- Sep 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of golimumab in peripheral spondyloarthritis (pSpA), sponsored by Ghent University Hospital. Primary endpoint: Clinical remission induction and prevention of new spondyloarthritis signs. Started Sep 2011; status: completed.
02
Drugs
golimumab
03
Conditions
peripheral spondyloarthritis (pSpA)
Beyond the preview
Go deeper on 2011-003678-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003678-97.